Portfolio company
Mecox Curemed
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This pharmaceutical company develops drug delivery systems and oncology treatments for healthcare providers and patients through platform-based drug development.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Meliora Therapeutics
This company develops a machine-learning platform to identify drug mechanisms and create precision oncology treatments for pharmaceutical partners and cancer patients.
Oncko
This company develops multi-drug cancer therapies and clinical platform trials to identify optimal treatment combinations and schedules for pharmaceutical partners and patients.
Oncosyne
This company develops patient-derived tumoroid drug screening platforms for pharmaceutical firms and oncologists to improve drug discovery and personalised cancer treatment.
Icure Pharmceutical
This company develops and manufactures transdermal drug delivery systems, pharmaceutical patches and cosmeceutical products for healthcare providers and retail consumers.
Depomed
This pharmaceutical company develops and markets branded prescription medicines for patients with neurology, oncology, and inflammatory conditions.
NaDeNo
This company develops a nanotechnology drug delivery platform for pharmaceutical partners to encapsulate hydrophobic small molecule drugs for targeted cancer treatments.
Akanocure Pharmaceuticals
This company develops small molecule drugs targeting orphan and unmet needs in oncology for healthcare providers and patients.
RS Research
This biotechnology company develops targeted nanomedicine delivery platforms and polymer-drug conjugates for oncology patients and pharmaceutical researchers.
